Clinical-stage biotechnology company leaders meeting

Leadership

InGeneron is led by an international team of bold innovators
creating the next generation of life changing therapeutics.

Management Team Board of Directors

Management Team

Fabian Alt, Chief Financial Officer at InGeneron

Fabian Alt, M.Sc.

Chief Financial Officer
Fabian Alt, Chief Financial Officer at InGeneron

Fabian Alt, M.Sc.

Chief Financial Officer

Fabian Alt previously served in the Investment Banking Division of Goldman Sachs’s London office. His experience extends across more than 20 completed capital market and M&A transactions, including several equity capital offerings and IPOs. Fabian received his master’s in finance from the London School of Economics and Political Science, earned an honors master’s in technology management from the Technical University of Munich and Ludwig-Maximilians-University Munich, and received a master’s in physics from the Technical University of Munich. In addition, he completed research stays at the Max Planck Institute for Quantum Optics and Massachusetts Institute of Technology.

Portrait of David Mercer, Director of Engineering and Product Operations at InGeneron

David Mercer

Director of Engineering and Product Operations
Portrait of David Mercer, Director of Engineering and Product Operations at InGeneron

David Mercer

Director of Engineering and Product Operations

David Mercer has more than 12 years of product development experience in medical devices. Previously, he worked at Acelity as Lead Product Development Engineer developing new negative pressure therapy devices within the Prevena and Abthera surgical product lines. Before Acelity David developed mechanical and electromechanical drug delivery systems at DCA Design International in the UK. David received his degree in mechanical engineering specializing in product design from The University of Glasgow.

Portrait of Christopher Alt, MD Director of Medical and Scientific Affairs at InGeneron

Christopher Alt, MD

Director of Medical and Scientific Affairs
Portrait of Christopher Alt, MD Director of Medical and Scientific Affairs at InGeneron

Christopher Alt, MD

Director of Medical and Scientific Affairs

Christopher Alt has 15 years of research experience in medicine and has a proven track record of clinical trial management. Previously, he worked at MD Anderson Cancer Center in the department of molecular pathology. Christopher joined InGeneron in 2015 as European director of medical and scientific affairs before taking on the role of global director of medical and scientific affairs in 2020. Christopher received his medical degree from PMU Salzburg in Austria.

Portrait of Christoph Schmitz, Advisory Medical Director at InGeneron

Christoph Schmitz, MD, PhD

Advisory Medical Director
Portrait of Christoph Schmitz, Advisory Medical Director at InGeneron

Christoph Schmitz, MD, PhD

Advisory Medical Director

Dr. Christoph Schmitz is Full Professor of Anatomy and Head of the Department of Anatomy II at Ludwig-Maximilians-University of Munich (Munich, Germany). He is one of the leading basic and clinical scientists in the field of extracorporeal shock wave therapy (ESWT) of the musculoskeletal system, with more than 40 related publications out of more than 200 publications listed in PubMed.
His formal medical training includes a M.D. degree and a Ph.D. degree equivalent (“Habilitation”) from RWTH Aachen University (Aachen, Germany). He is also active in a number of professional societies and related organizations, among them the Clinical Sciences & Research Committee of the International Society of Physical and Rehabilitation Medicine (ISPRM). Dr. Schmitz has been awarded more than 2,5 million euros in peer reviewed grants as Principal Investigator. He is currently involved in a number of scientific collaboration projects on ESWT with professional soccer clubs in Germany, as well as with leading specialists on physical and rehabilitation medicine in Europe, Latin America and China.

Portrait of Robert T. Charles, Director of Quality at InGeneron.

Robert T. Charles

Director of Quality
Portrait of Robert T. Charles, Director of Quality at InGeneron.

Robert T. Charles

Director of Quality

Robert Charles has over 30 years of experience in quality and reliability assurance management in the medical industry. He has held leadership position at several large healthcare companies including Cyberonics, Intermedics, Abbott Laboratories, and St. Jude Medical. He has a proven track record of quality planning, operation, and management.

Portrait of Annete M. Zinn, Director of Regulatory Affairs at InGeneron.

Annette M. Zinn, J.D., Ph.D.

Director of Regulatory Affairs
Portrait of Annete M. Zinn, Director of Regulatory Affairs at InGeneron.

Annette M. Zinn, J.D., Ph.D.

Director of Regulatory Affairs

Annette M. Zinn, J.D., Ph.D., is a regulatory attorney with over 25 years of regulatory experience in the medical device industry. Previously she was regulatory counsel at Cyberonics for 13 years and regulatory specialist at Intermedics, Inc. for 7 years. During her career she has overseen successful pre-market approval applications (PMA) to the U.S. Food and Drug Administration. She instructed LLM students in FDA law and regulations at the University of Houston, Bates College of Law. She has a law degree from South Texas College of Law and is licensed to practice in the State of Texas. She has both M.P.H. and Ph.D. degrees from the University of Texas Houston, School of Public Health, where her research included the effect of modernization laws on FDA/CMS approvals.

Portrait of Marcos Garcia, Director of Manufacturing and Supply Chain at InGeneron

Marcos Garcia

Director of Manufacturing and Supply Chain
Portrait of Marcos Garcia, Director of Manufacturing and Supply Chain at InGeneron

Marcos Garcia

Director of Manufacturing and Supply Chain

Marcos has over 30 years of experience in manufacturing leadership In Aerospace, Electronics and Medical Devices. He has led plant operations as large as six hundred employees and managed manufacturing operations for class 3 active implantable medical devices with Cyberonics/Livanova. Marcos has a bachelor’s degree in Industrial Engineering, a master’s in Electrical Engineering and an MBA.

Board of Directors

Portrait of Eckhard Alt MD., Executive Chairman at InGeneron

Eckhard Alt, MD, PhD

Executive Chairman
Portrait of Eckhard Alt MD., Executive Chairman at InGeneron

Eckhard Alt, MD, PhD

Executive Chairman

Eckhard U. Alt is professor of medicine and biomedical engineering at Tulane University in New Orleans and was professor of medicine at University of Texas MD Anderson Cancer Center in Houston and at Technical University of Munich. He received his medical degree as valedictorian from Heidelberg Medical School. After two years in cardiac surgery at the Ludwig-Maximilians-University Munich, he completed his education at Technical University of Munich in internal medicine/cardiology.

Eckhard is a frequent reviewer and serves on the editorial boards of respected journals. From 2001 to 2007, he was president of the Cardiac Electrophysiology Society. He has organized major national and international congresses; authored more than 500 publications in peer-reviewed journals, books, or book chapters; and has acquired more than 600 worldwide patents, primarily in the fields of stem cells, electrophysiology, and interventional cardiology. The magazine Focus rated him among the “Best 12 Cardiologists in Germany.” Eckhard received the Hahn Research Award from the European Society of Thoracic Surgeons as well as the Ethica Award as Best Experimental Researcher from Erasmus University in Rotterdam. In 2009, he was named Entrepreneur of the Year in Munich and Innovator of the Year in Houston. In addition to being Executive Chairman of InGeneron, Inc., he is also chairman of the board of ISAR Klinikum in Munich, Germany.

Portrait of Klaus L. Keller, Director at InGeneron

Klaus L. Keller

Director
Portrait of Klaus L. Keller, Director at InGeneron

Klaus L. Keller

Director

Klaus L. Keller is founding chairman, CEO, and majority shareholder of Sueba USA Corporation in Houston, Texas. He is active in the areas of acquisition, development, and management of U.S. real estate and real estate investment funds. Klaus is also a private investor and syndicator.

Portrait of Jerry Griffin, Director at InGeneron

Jerry Griffin

Director
Portrait of Jerry Griffin, Director at InGeneron

Jerry Griffin

Director

Jerry C. Griffin is president of Griffin & Schwartz, Scientific Services Inc., a management consulting firm in the health care products field. He has assisted several development stage companies in areas ranging from venture and public financing to FDA and clinical trial strategy. He is currently a member of the boards of directors of a number of private companies. During his academic tenure, Jerry held leadership positions in several national and international cardiology organizations and is the author or coauthor of five books, four patents, and over 170 medical and scientific articles.

Untitled design (60)

Bobby I. Griffin, PhD

Director
Untitled design (60)

Bobby I. Griffin, PhD

Director

Bobby I. Griffin retired from a 25-year career with Medtronic, Inc., where he held various executive-level positions, including president of Medtronic’s CRM Business from 1991 to 1998. He manages his own fund of companies and serves on the advisory boards of Affinity Capital Management Fund III and IV and Sapient Capital Management Fund, in which he also invests. In addition, Bobby has served on the board of directors of several public companies, including MTS Systems Corporation and Urologix, Inc., and is currently a director of several private companies.

Portrait of Amber Langner, CPA, CHFP, Director at InGeneron

Amber Langner, CPA, CHFP

Director
Portrait of Amber Langner, CPA, CHFP, Director at InGeneron

Amber Langner, CPA, CHFP

Director

Amber Langner is VP Treasury for Sanford Health and has significant financial experience in the Healthcare Industry. She offers a wealth of knowledge in financial planning, forecast analysis, financial systems strategy implementation, and accounting. Amber spent 5 years at Sanford leading innovative changes to the accounting and finance department and she continues to push for efficiency and innovation in her new role as VP Treasury.

Portrait of Kent Lehr, Director at InGeneron and chief business development officer at Sanford Health

Kent Lehr

Director
Portrait of Kent Lehr, Director at InGeneron and chief business development officer at Sanford Health

Kent Lehr

Director

Kent Lehr is chief business development officer at Sanford Health and oversees Sanford Health’s business development strategy, growth initiatives, innovative partnerships, and commercialization efforts. Lehr joined Sanford Health in 2020 after a decade-long career with UnityPoint Health, where he started as an administrative fellow before holding several leadership positions in strategic growth and business development. He most recently served as UnityPoint Health’s vice president of strategy and business development.

A native of Des Moines, Iowa, Lehr holds a bachelor’s degree in biochemistry and molecular biology from Cornell College (Iowa) and a Master of Business Administration and Master of Health Administration from the University of Iowa.